Clinical Trial Type: Gastric

Name of this trial: Gemini-PeriOp What type of cancer is this for? Gastroesophageal Cancer Who is this trial for? Patients with locally advanced, resectable gastroesophageal cancer What biomarkers are involved? Multiple cohorts include CLDN18.2, HER2 positive, and all-comers What is the National Clinical Trial #? NCT07069712  Brief summary of this trial: Open-Label, Multi-Drug, Multi-Center, Phase